Adrian Harel/LinkedIn
Jun 17, 2026, 16:29
Adrian Harel: Medicortex’s Review on Diagnostic Biomarkers of Ischemic Stroke Is Live Now
Adrian Harel, Founder and CEO at Medicortex Finland Oyj, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers, adding:
”Medicortex’s review article on diagnostic biomarkers of ischemic stroke was just published.”
Title: Diagnostic biomarkers of ischemic stroke: strengths and limitations across blood, urine, and saliva
Authors: Begüm Utz, Pihla Miettinen, Ivette Bañuelos-Cabrera, Leonardo Lara-Valderrábano, Lasse Välimaa, Adrian Harel
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge